In vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model

J Pharmacol Sci. 2016 Sep;132(1):48-54. doi: 10.1016/j.jphs.2016.05.001. Epub 2016 May 18.

Abstract

We assessed electrophysiological effects of an atypical antipsychotic drug paliperidone in acute atrioventricular block rabbits. Intravenous administration of paliperidone at a clinically relevant dose (0.06 mg/kg) hardly affected the QT interval or monophasic action potential (MAP) duration, and the higher doses (0.6 and 6 mg/kg) prolonged the QT interval and MAP duration. Meanwhile, premature ventricular contractions with R on T phenomenon were observed in 3 out of 6 animals at the middle dose, and torsades de pointes (TdP) episodes were detected in 2 out of 6 animals at the high dose. Intravenous administration of its chemically related compound risperidone at a clinically relevant dose (0.03 mg/kg) hardly affected the electrophysiological parameters, and the higher doses (0.3 and 3 mg/kg) prolonged the QT interval and MAP duration. Meanwhile, the premature ventricular contractions with R on T were observed in 2 out of 6 animals at the middle dose, and TdP episodes were detected in 4 out of 6 animals at the high dose. These results suggest that paliperidone showed torsadogenic potential at supra-therapeutic doses, whose potency can be estimated to be equal or slightly subordinate in comparison with that of risperidone.

Keywords: Atrioventricular block; Paliperidone; QT prolongation; Torsades de pointes.

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Antipsychotic Agents / adverse effects*
  • Atrioventricular Block
  • Dose-Response Relationship, Drug
  • Male
  • Paliperidone Palmitate / adverse effects*
  • Rabbits
  • Risperidone / adverse effects
  • Torsades de Pointes / chemically induced*

Substances

  • Antipsychotic Agents
  • Risperidone
  • Paliperidone Palmitate